CARGO Therapeutics, Inc.
Why Robinhood?
You can watch CRGX and buy or sell other stocks, ETFs, and their options commission-free!About CRGX
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy.
CRGX Key Statistics
Stock Snapshot
With a market cap of 207.85M, CARGO Therapeutics, Inc.(CRGX) trades at $4.47. The stock has a price-to-earnings ratio of -0.96.
On 2026-05-16, CARGO Therapeutics, Inc.(CRGX) stock opened at —, reached a high of —, and a low of —.
The CARGO Therapeutics, Inc.(CRGX)'s current trading volume is 0, compared to an average daily volume of 1.25M.
In the last year, CARGO Therapeutics, Inc.(CRGX) shares hit a 52-week high of $25.45 and a 52-week low of $3.00.
In the last year, CARGO Therapeutics, Inc.(CRGX) shares hit a 52-week high of $25.45 and a 52-week low of $3.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.